What is ABGRAT Medical Intelligence?

ABGRAT is a global medical intelligence platform that analyzes breakthroughs from WHO, NIH, CDC, and NEJM using AI to deliver clinical insights to healthcare professionals.

How does ABGRAT analyze medical news?

ABGRAT uses deterministic medical logic combined with adaptive AI reasoning to process and validate medical articles, providing summaries, clinical significance, and risk assessments.

What medical specialties does ABGRAT cover?

ABGRAT covers Oncology, Cardiology, Neurology, Genetics, Medical AI, Infectious Diseases, Obstetrics, Surgery, Radiology, Public Health, Emergency Medicine, and more.

Is ABGRAT a substitute for professional medical advice?

No. ABGRAT provides AI-generated clinical insights for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Home Medical News[Articles] Detection of young-onset type 2 diabetes using deep learning across primary and secondary care: a nationwide, retrospective cohort study

General Medicinegeneral

[Articles] Detection of young-onset type 2 diabetes using deep learning across primary and secondary care: a nationwide, retrospective cohort study

The Lancet Digital HealthApril 22, 20263 min readReliability 99%

Written & Analyzed by

Abgrat Medical Intelligence Team

Published: April 22, 2026

Medically Reviewed by

Abgrat Medical Review Board

Board-certified physicians and AI researchers

Source Reliability: 99%Last Reviewed: May 2026

Cross-referenced with trusted medical databases:

WHO GuidelinesNIH PubMedCDC Clinical ResourcesNEJM Evidence

⚕️ This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.

This study highlights the potential for using deep learning methods on longitudinal health data from both primary and secondary care to develop low-cost predictive tools for screening of young-onset t